Get started
Live feed
·
INSIDERFilingvia Quantisnow
Maze Therapeutics Inc. logo

CSBO Dandekar Atul sold $240,532 worth of shares (7,500 units at $32.07) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.
Quantisnow market dataNASDAQ
Maze Therapeutics Inc. logo
MAZE
Maze Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2025
Get push alerts for MAZE

Follow MAZE and get a push notification the moment its next story breaks.

Full MAZE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MAZE (Maze Therapeutics Inc.) and more on Quantisnow.